2026-01-23 - Analysis Report
# UnitedHealth Group (UNH) Financial Analysis Report

## 1. Company Overview

UnitedHealth Group is a diversified health care company providing health insurance and benefits, as well as care delivery and health management services.

## 2. Comparison with S&P 500 (VOO)

| Date | Cumulative Return of Review Stock | Cumulative Return of Comparison Stock (VOO) | Divergence | Relative Divergence |
| --- | --- | --- | --- | --- |
| N/A | -15.97% | 92.53% | -108.50% | 6.30% |

## 3. Alpha, Beta Analysis

| Period | CAGR | MDD | Alpha | Beta | Cap(B) |
| --- | --- | --- | --- | --- | --- |
| 2016-2018 | 22.0% | 18.6% | 18.0% | 0.90 | 225.7B |
| 2017-2019 | 27.0% | 18.6% | 10.0% | 0.90 | 266.3B |
| 2018-2020 | -41.0% | 32.5% | -62.0% | 1.10 | 317.7B |
| 2019-2021 | 16.0% | 32.5% | -27.0% | 1.10 | 454.9B |
| 2020-2022 | 0.0% | 31.5% | 2.0% | 0.90 | 480.3B |
| 2021-2023 | 23.0% | 13.4% | 23.0% | 0.50 | 476.9B |
| 2022-2024 | -24.0% | 23.1% | -44.0% | 0.40 | 458.2B |
| 2023-2025 | -55.0% | 58.5% | -118.0% | 0.30 | 299.0B |

## 4. Recent Stock Price Fluctuations

| Indicator | Value |
| --- | --- |
| Close | $354.47 |
| Last-Market Change | 1.93% |
| 5-day SMA | $342.13 |
| 20-day SMA | $337.77 |
| 60-day SMA | $333.08 |

## 5. RSI, PPO Index Indicators, and Delta_Previous_Relative_Divergence

| Indicator | Value |
| --- | --- |
| Market Risk Indicator (MRI) | 0.90 |
| RSI | 65.11 |
| PPO | 0.31 |
| Hybrid Signal: Buy | Cash 0% |
| Risk Level | High |
| Recent (20 days) relative divergence change | -1.60% (worsening) |
| 7-day Rank change | 46 (+) (rank up) |
| 7-day Dynamic Expected Return change | -58.80% (worsening) |
| Expected Return (%) | -356.70% |

## 6. Recent News & Significant Events

- [2026-01-22] Don't Buy UnitedHealth Group Stock Before Jan. 27 - The Motley Fool
- [2026-01-20] Why Is Wall Street Bullish on UnitedHealth Stock (UNH) Ahead of Q4 Earnings? - TipRanks
- [2026-01-21] Dear UnitedHealth Stock Fans, Mark Your Calendars for January 27 - Yahoo Finance
- [2026-01-21] UnitedHealth rebating profits from ACA plans to customers (UNH:NYSE) - Seeking Alpha
- [2026-01-19] Should you load up on UnitedHealth stock ahead of January 27th? - TradingView
- [2026-01-19] Is UnitedHealth Group (UNH) Pricing Reflect Its Value After Prolonged Share Price Weakness - Yahoo Finance

## 7. Analyst Opinions

Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 1.93 (~Buy)
- Opinions: 26
- Target Price (avg/high/low): $393.85 / $444.00 / $280.00

## 8. Recent Earnings Analysis

| Date | EPS | Revenue |
| --- | --- | --- |
| 2025-10-28 | 2.59 | $113.16B |
| 2025-08-11 | 3.76 | $111.62B |
| 2025-05-07 | 6.90 | $109.58B |
| 2024-11-04 | 6.56 | $100.82B |
| 2025-10-28 | 6.56 | $100.82B |

## 9. Financial Information - Revenue and Profitability

| Quarter | Revenue | Profit Margin |
| --- | --- | --- |
| 2025-09-30 | $113.16B | 18.24% |
| 2025-06-30 | $111.62B | 17.93% |
| 2025-03-31 | $109.58B | 21.70% |
| 2024-12-31 | $100.81B | 21.14% |
| 2024-09-30 | $100.82B | 22.84% |

## 10. Financial Information - Capital and Profitability

| Quarter | Equity | ROE |
| --- | --- | --- |
| 2025-09-30 | $95.79B | 2.45% |
| 2025-06-30 | $94.72B | 3.60% |
| 2025-03-31 | $95.04B | 6.62% |
| 2024-12-31 | $92.66B | 5.98% |
| 2024-09-30 | $94.53B | 6.41% |

## 11. Comprehensive Analysis (Summary of previous items)

Based on the provided data, UnitedHealth Group's stock has a negative cumulative return rate, indicating a decline in value over time. The company's recent price fluctuations show a slight rebound, but its moving average values (5-day, 20-day, 60-day) are still below the current price. The RSI and PPO index indicators suggest a relatively neutral market risk, but the hybrid signal suggests a buy opportunity with caution. The expected return rate is significantly negative, indicating a potential loss for investors.

Recent news and significant events highlight the company's rebating of profits from ACA plans to customers and analyst opinions suggest a buy recommendation with a target price of $393.85. The earnings analysis shows a decline in earnings per share (EPS) and revenue over the past quarters.

Overall, UnitedHealth Group's financial performance and market indicators suggest a cautious approach to investing in the company's stock.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.